Clinical Trials Browser

Active not recruiting × Tumor-Agnostic × 30 days × Clear all

NCT04452955 2026-04-22

A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors

Phase 2 Active not recruiting

Neoplasms

NCT05638295 2026-04-22

Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)

Phase 2 Active not recruiting

Neoplasm Metastasis

NCT06555744 2026-04-22

A Study of ZW191 in Participants With Solid Tumors

Phase 1 Active not recruiting

Neoplasms

NCT04637035 2026-04-21

Supportive Oncology Care at Home Post-Discharge

Phase NA Active not recruiting

Neoplasms

NCT02646384 2026-04-20

Ovarian Tissue Cryopreservation in Children

Phase NA Active not recruiting

Neoplasms

NCT02243592 2026-04-17

Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment

Active not recruiting

Neoplasms

NCT01187199 2026-04-16

Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer

Phase 1 Active not recruiting

Neoplasm Metastasis

NCT02911064 2026-04-16

Expectations Regarding Mobility and Self-Care

Active not recruiting

Neoplasms

NCT05836857 2026-04-16

The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study

Active not recruiting

Neoplasms

NCT02337452 2026-04-15

Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families

Active not recruiting

Neoplasms

NCT02387905 2026-04-15

Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases

Phase 2 Active not recruiting

Neoplasm Metastasis

NCT03671226 2026-04-15

Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center

Phase NA Active not recruiting

Neoplasm Metastasis

NCT04464226 2026-04-15

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

Phase 3 Active not recruiting

Neoplasms

NCT04957615 2026-04-15

Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 Expression

Phase 2 Active not recruiting

Neoplasm Metastasis

NCT05347212 2026-04-15

Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla

Phase 2 Active not recruiting

Carcinoma

NCT03768336 2026-04-14

A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors

Phase NA Active not recruiting

72 enrolled 8 charts

Neoplasms

NCT04958239 2026-04-14

A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer

Phase 1 Active not recruiting

Neoplasms

NCT05611632 2026-04-14

NHS-Galleri

Phase NA Active not recruiting

142,318 enrolled

Neoplasms

NCT02908906 2026-04-13

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers

Phase 1/2 Active not recruiting

Neoplasms

NCT03030378 2026-04-13

Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors

Phase 1 Active not recruiting

Neoplasm Metastasis

NCT03148418 2026-04-13

A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

Phase 3 Active not recruiting

Neoplasms

NCT04317105 2026-04-13

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN

Phase 1/2 Active not recruiting

Neoplasm Metastasis

NCT04520711 2026-04-13

Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)

Phase 1 Active not recruiting

Carcinoma

NCT04606381 2026-04-13

PALOMA

Phase 1 Active not recruiting

Neoplasms

NCT05155605 2026-04-13

PATHFINDER 2: A Multi-Cancer Early Detection Study

Phase NA Active not recruiting

35,885 enrolled

Neoplasms

NCT05554341 2026-04-13

Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial

Phase 2 Active not recruiting

Neoplasm Metastasis

NCT01706939 2026-04-09

The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer

Phase 3 Active not recruiting

23 enrolled 19 charts

Carcinoma, Squamous Cell

NCT04847466 2026-04-08

Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer

Phase 2 Active not recruiting

Neoplasms

NCT05479708 2026-04-08

ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma

Active not recruiting

Neoplasm, Residual

NCT05993299 2026-04-08

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Phase 2 Active not recruiting

7 enrolled 15 charts

Neoplasms

NCT06703346 2026-04-08

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Phase 2 Active not recruiting

Neoplasms

NCT06745024 2026-04-08

Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial

Phase 3 Active not recruiting

Neoplasm Metastasis

NCT06939452 2026-04-07

A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression

Phase 2 Active not recruiting

Adenocarcinoma

NCT05112965 2026-04-06

An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)

Phase 3 Active not recruiting

Neoplasms

NCT05261399 2026-04-06

SAFFRON

Phase 3 Active not recruiting

Carcinoma, Neoplasm Metastasis

NCT05629234 2026-04-06

ROSY-T

Phase 3 Active not recruiting

Neoplasms

NCT05784766 2026-04-06

SARIC

Phase NA Active not recruiting

Neoplasms

NCT02584933 2026-04-02

Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study

Phase 4 Active not recruiting

Neoplasms

NCT04713046 2026-04-02

Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers

Phase 1/2 Active not recruiting

Neoplasm Metastasis

NCT06018753 2026-04-02

Polaris

Active not recruiting

10,000 enrolled

Neoplasms

NCT06926972 2026-04-01

NOURISH

Phase NA Active not recruiting

Neoplasms

NCT07321392 2026-03-31

Psychometric Validation of the Psychosocial Assessment Tool in Caregivers of Pediatric Cancer Patients.

Active not recruiting

Neoplasms

NCT04050072 2026-03-30

Patient-Reported Outcome Version of the Common Criteria for Adverse Events

Active not recruiting

Neoplasms

NCT03809377 2026-03-27

Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2)

Active not recruiting

Neoplasms

NCT04538482 2026-03-27

DINING

Phase NA Active not recruiting

Neoplasms